The original shielding letters and advice that have been sent out to people who are highly vulnerable to COVID-19 (coronavirus) infection stated that all recipients of the letter should completely isolate themselves from physical contact, not go outside of their homes for 12 weeks.
This advice was sent to all patients of the National Aspergillosis Centre (NAC) who have chronic pulmonary aspergillosis (CPA).
Patients who have allergic bronchopulmonary aspergillosis (ABPA), severe asthma and forms of aspergillosis other than CPA were informed of their vulnerability status by their local respiratory clinic or GP. Some will have been told to shield, others not but all shielding advice was to remain in place for 12 weeks from the day of receipt of the letter.
That advice for people shielding has now been amended to say that all shielding people should continue shielding until the end of June 2020.
Latest advice from Welsh government
Share this post
Latest News posts
Herd immunity to COVID-19 – is it achievable?
October 28, 2021
Walk and paint yourself back to health & wellbeing
October 14, 2021
Antifungal Drug Pipeline
October 8, 2021
Is it COVID or just a cold?
September 24, 2021
World Sepsis Day 2021
September 13, 2021
Aspergillosis and Depression: A Personal Reflection
September 1, 2021
Therapeutic drug monitoring (TDM)
August 9, 2021
When will there be a vaccine for aspergillosis?
July 16, 2021
Palliative Care – Not What You Might Think
June 15, 2021
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video